LRRC42 antibody
Principal name
LRRC42 antibody
Alternative names for LRRC42 antibody
Leucine-rich repeat-containing protein 42
Ncbi ID
NP_443172, NP_443172.1, NM_052940, NP_084261.1, NM_001025653
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of LRRC42 antibody
- Kit Component:
- - KN309468G1, Lrrc42 gRNA vector 1 in pCas-Guide vector
- KN309468G2, Lrrc42 gRNA vector 2 in pCas-Guide vector
- KN309468D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Human HT1080; WB Suggested Anti-LRRC42 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: HT1080 cell lysate. LRRC42 is supported by BioGPS gene expression data to be expressed in HT1080.; LRRC42 antibody - N-terminal region (ARP52459_P050) in Human HT1080 cells using Western Blot
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301955 | LRRC42 |
||||
| Recombinant protein of human leucine rich repeat containing 42 (LRRC42) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY409375 | LRRC42 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR211094L2V | Lenti ORF particles, Lrrc42 (GFP-tagged ORF) - Rat leucine rich repeat containing 42 (Lrrc42), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR211094L1V | Lenti ORF particles, Lrrc42 (Myc-DDK-tagged ORF) - Rat leucine rich repeat containing 42 (Lrrc42), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||



